Additional file 2: eFigure 2. a) Disease-free survival in the two skeletal muscle index groups at relapse. b) Overall survival in the two skeletal muscle index groups at relapse.
BackgroundAlthough biological resources are essential for basic and preclinical research in the oncological field, those of sarcoma are not sufficient for rapid development of the treatment. So far, s
Comparison of natural history (NH) cohort with chemotherapy (CT) cohort. 1Performance score–performance score using Zubrod scale, 2OS–overall survival, 3MFS–metastatic-free survival, 4response to CT–r